MedTrace Logo

A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD

NCT00105911 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2015-04-07

No results posted yet for this study

Summary

The literature and our preliminary studies found that in COPD patients, psychosocial factors affect quality of life (QOL) and functioning more than would be expected given the severity of their disease. To improve QOL and functioning in the approximately 50% of COPD patients with significant anxiety and/or depressive symptoms, interventions are needed. Much research documents the utility of cognitive behavioral therapy (CBT) in treating depression and anxiety, showing it to have promise as a self-management intervention to improve QOL in COPD patients.

Conditions

  • Depressive Disorders
  • Anxiety Disorders
  • Pulmonary Disease, Chronic Obstructive

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

Sponsors & Collaborators

Principal Investigators

  • Mark E. Kunik, MD MPH · Michael E. DeBakey VA Medical Center, Houston, TX

Study Design

Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00105911 on ClinicalTrials.gov